Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mei Kohama

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Therapeutic Innovation & Regulatory Science|August 13, 2022
Descriptive Analysis for the Trend of Pharmacovigilance Planning in Risk Management Plans on New Drugs Approved During 2016-2019Mei Kohama, Takahiro Nonaka, Yoshiaki Uyama, et al.
Pharmacoepidemiology and Drug Safety|June 15, 2019
Identification of gastrointestinal perforation based on ICD-10 code in a Japanese administrative medical information database and associated drug exposure risk factorsMasatoshi Tanigawa, Yoko Kataoka, Takayoshi Kishino, et al.
Therapeutic Innovation & Regulatory Science|April 21, 2024
Detection Algorithms for Gastrointestinal Perforation Cases in the Medical Information Database Network (MID-NET<sup>®</sup>) in JapanMasatoshi Tanigawa, Mei Kohama, Kaori Hirata, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 10, 2025
Risk of liver dysfunction with ACE inhibitors based on real-world data from the MID-NET<sup>®</sup> in JapanYuki Kinoshita, Takashi Ando, Kazuhiro Kajiyama, et al.
Therapeutic Innovation & Regulatory Science|October 30, 2023
Lower Risks of Gastrointestinal Perforation and Intestinal Obstruction in Patients with Atypical Antipsychotics in Comparison with Typical Antipsychotics Based on Real-World Data from the MID-NET<sup>®</sup> in JapanTomoaki Hasegawa, Sono Sawada, Tomoyuki Saito, et al.
Pharmacoepidemiology and Drug Safety|February 28, 2022
Validity of identification algorithms combining diagnostic codes with other measures for acute ischemic stroke in MID-NET®Masatoshi Tanigawa, Mei Kohama, Takahiro Nonaka, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Therapeutic Innovation & Regulatory Science|August 13, 2022
Descriptive Analysis for the Trend of Pharmacovigilance Planning in Risk Management Plans on New Drugs Approved During 2016-2019Mei Kohama, Takahiro Nonaka, Yoshiaki Uyama, et al.
Pharmacoepidemiology and Drug Safety|June 15, 2019
Identification of gastrointestinal perforation based on ICD-10 code in a Japanese administrative medical information database and associated drug exposure risk factorsMasatoshi Tanigawa, Yoko Kataoka, Takayoshi Kishino, et al.
Therapeutic Innovation & Regulatory Science|April 21, 2024
Detection Algorithms for Gastrointestinal Perforation Cases in the Medical Information Database Network (MID-NET<sup>®</sup>) in JapanMasatoshi Tanigawa, Mei Kohama, Kaori Hirata, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 10, 2025
Risk of liver dysfunction with ACE inhibitors based on real-world data from the MID-NET<sup>®</sup> in JapanYuki Kinoshita, Takashi Ando, Kazuhiro Kajiyama, et al.
Therapeutic Innovation & Regulatory Science|October 30, 2023
Lower Risks of Gastrointestinal Perforation and Intestinal Obstruction in Patients with Atypical Antipsychotics in Comparison with Typical Antipsychotics Based on Real-World Data from the MID-NET<sup>®</sup> in JapanTomoaki Hasegawa, Sono Sawada, Tomoyuki Saito, et al.
Pharmacoepidemiology and Drug Safety|February 28, 2022
Validity of identification algorithms combining diagnostic codes with other measures for acute ischemic stroke in MID-NET®Masatoshi Tanigawa, Mei Kohama, Takahiro Nonaka, et al.
Pageof 1